更正“使用抗血管生成药物提高抗肿瘤免疫:机制见解、当前进展和临床挑战”。

IF 24.9 1区 医学 Q1 ONCOLOGY
{"title":"更正“使用抗血管生成药物提高抗肿瘤免疫:机制见解、当前进展和临床挑战”。","authors":"","doi":"10.1002/cac2.70060","DOIUrl":null,"url":null,"abstract":"<p>Shu-Jin Li<sup>1</sup>, Jia-Xian Chen<sup>1</sup>, Zhijun Sun<sup>1,2</sup></p><p><sup>1</sup>The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) &amp; Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, Hubei, People's Republic of China</p><p><sup>2</sup>Department of Oral Maxillofacial-Head Neck Oncology, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, Hubei, People's Republic of China</p><p>Shu-Jin Li and Jia-Xian Chen contributed equally to this work.</p><p><b>Correspondence</b>: Zhijun Sun (<span>[email protected]</span>)</p><p>Following the publication of this article [1], it has come to our attention that proper citations were inadvertently omitted when introducing the concept of “immunostimulatory vascular-modulating cycle” and its illustration in Figure 4. The concept was originally proposed by Khan and Kerbel (2018) [2].</p><p>The revised text now reads:</p><p>“<i>An immunostimulatory vascular-modulating cycle has been proposed to explain the synergistic effects observed between antiangiogenic agents and cancer immunotherapy, based on the mutual regulation between vascular normalization and immune responses</i> [2] (Figure 4).”</p><p>The revised Figure 4 is provided below:</p><p>We sincerely apologize for our mistake.</p><p>[1] Li SJ, Chen JX, Sun ZJ. Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges. Cancer Commun. 2021;41(9):830–50.</p><p>[2] Khan KA, Kerbel RS. Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa. Nat Rev Clin Oncol. 2018;15(5):310–24.</p>","PeriodicalId":9495,"journal":{"name":"Cancer Communications","volume":"45 10","pages":"1339-1340"},"PeriodicalIF":24.9000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cac2.70060","citationCount":"0","resultStr":"{\"title\":\"Correction to “Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges”\",\"authors\":\"\",\"doi\":\"10.1002/cac2.70060\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Shu-Jin Li<sup>1</sup>, Jia-Xian Chen<sup>1</sup>, Zhijun Sun<sup>1,2</sup></p><p><sup>1</sup>The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) &amp; Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, Hubei, People's Republic of China</p><p><sup>2</sup>Department of Oral Maxillofacial-Head Neck Oncology, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, Hubei, People's Republic of China</p><p>Shu-Jin Li and Jia-Xian Chen contributed equally to this work.</p><p><b>Correspondence</b>: Zhijun Sun (<span>[email protected]</span>)</p><p>Following the publication of this article [1], it has come to our attention that proper citations were inadvertently omitted when introducing the concept of “immunostimulatory vascular-modulating cycle” and its illustration in Figure 4. The concept was originally proposed by Khan and Kerbel (2018) [2].</p><p>The revised text now reads:</p><p>“<i>An immunostimulatory vascular-modulating cycle has been proposed to explain the synergistic effects observed between antiangiogenic agents and cancer immunotherapy, based on the mutual regulation between vascular normalization and immune responses</i> [2] (Figure 4).”</p><p>The revised Figure 4 is provided below:</p><p>We sincerely apologize for our mistake.</p><p>[1] Li SJ, Chen JX, Sun ZJ. Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges. Cancer Commun. 2021;41(9):830–50.</p><p>[2] Khan KA, Kerbel RS. Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa. Nat Rev Clin Oncol. 2018;15(5):310–24.</p>\",\"PeriodicalId\":9495,\"journal\":{\"name\":\"Cancer Communications\",\"volume\":\"45 10\",\"pages\":\"1339-1340\"},\"PeriodicalIF\":24.9000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cac2.70060\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Communications\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cac2.70060\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Communications","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cac2.70060","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

武汉大学口腔医学院口腔生物医学教育部重点实验室,武汉430079;武汉大学口腔医学院口腔颌面头颈肿瘤科,武汉430079;中华人民共和国李淑瑾和陈家贤对这项工作作出了同样的贡献。在b[1]这篇文章发表后,我们注意到在介绍“免疫刺激血管调节周期”的概念及其图4中的说明时,无意中省略了适当的引用。这个概念最初是由Khan和Kerbel(2018)提出的。修订后的文本现在是:“基于血管正常化和免疫反应[2]之间的相互调节,已经提出了一个免疫刺激血管调节周期来解释抗血管生成药物和癌症免疫治疗之间观察到的协同效应(图4)。”修改后的图4如下:我们真诚地为我们的错误道歉。b[1]李士杰,陈建新,孙志军。使用抗血管生成药物提高抗肿瘤免疫:机制见解、当前进展和临床挑战。中华癌症杂志,2011;41(9):830-50Khan KA, Kerbel RS.抗血管生成治疗提高免疫治疗效果,反之亦然。中华疾病杂志,2018,15(5):310-24。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Correction to “Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges”

Correction to “Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges”

Shu-Jin Li1, Jia-Xian Chen1, Zhijun Sun1,2

1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, Hubei, People's Republic of China

2Department of Oral Maxillofacial-Head Neck Oncology, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, Hubei, People's Republic of China

Shu-Jin Li and Jia-Xian Chen contributed equally to this work.

Correspondence: Zhijun Sun ([email protected])

Following the publication of this article [1], it has come to our attention that proper citations were inadvertently omitted when introducing the concept of “immunostimulatory vascular-modulating cycle” and its illustration in Figure 4. The concept was originally proposed by Khan and Kerbel (2018) [2].

The revised text now reads:

An immunostimulatory vascular-modulating cycle has been proposed to explain the synergistic effects observed between antiangiogenic agents and cancer immunotherapy, based on the mutual regulation between vascular normalization and immune responses [2] (Figure 4).”

The revised Figure 4 is provided below:

We sincerely apologize for our mistake.

[1] Li SJ, Chen JX, Sun ZJ. Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges. Cancer Commun. 2021;41(9):830–50.

[2] Khan KA, Kerbel RS. Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa. Nat Rev Clin Oncol. 2018;15(5):310–24.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Communications
Cancer Communications Biochemistry, Genetics and Molecular Biology-Cancer Research
CiteScore
25.50
自引率
4.30%
发文量
153
审稿时长
4 weeks
期刊介绍: Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信